[Human lymphocyte immunophenotype after interaction with mesenchymal stromal cells]

Area of Science:

• Immunology
• Cell Biology
• Regenerative Medicine

Background:

• Mesenchymal stromal cells (MSCs) are immunomodulatory and have therapeutic potential.
• Understanding cell-to-cell interactions is crucial for clinical applications of allogeneic cell products.
• The impact of MSCs on different immune cell subsets requires detailed investigation.

Purpose of the Study:

• To investigate the effects of human multipotent mesenchymal stromal cells (MMSCs) on allogeneic blood-borne mononuclear cells (MNCs).
• To analyze changes in immune cell populations (B-cells, T-cells, NK cells) after coculture with MMSCs.
• To assess the influence of MNC maturity and activation state on MMSC interactions.

Main Methods:

• Coculture of MMSCs with allogeneic adult peripheral blood MNCs and umbilical cord blood MNCs (cbMNCs) for 72 hours.
• Analysis of immune cell subset proportions (B-cells, T-cells, NK cells, CD8+ T-cells) using flow cytometry.
• Evaluation of cell viability and expression of activation markers (HLA-DR, CD25) in monocultures and cocultures.

Main Results:

• Coculture with MMSCs decreased the proportion of B-cells among MNCs and cbMNCs.
• T-cell and NK cell proportions declined specifically in cbMNCs, with a reduction in the T-NK subpopulation in both MNC types.
• CD8+ T-cell counts dropped in cocultures with PHA-activated MNCs, while activated HLA-DR+ cells decreased and CD25+ cells increased.

Conclusions:

• MMSCs modulate the composition of allogeneic immune cell populations, affecting B-cell, T-cell, and NK cell subsets.
• MMSCs demonstrate a supportive role in maintaining the viability of various blood-borne immune cells.
• These findings provide insights into allogeneic cell interactions, relevant for the clinical use of combined stromal and blood-borne cell therapies.